Evidence map›Paper›PMID 38796645›Full record

SynthesisCommunications biology2024

Meta-analysis towards FSHD reveals misregulation of neuromuscular junction, nuclear envelope, and spliceosome.

Teresa Schätzl, Vanessa Todorow, Lars Kaiser, Helga Weinschrott, Benedikt Schoser, Hans-Peter Deigner, Peter Meinke, Matthias Kohl

Abstract readMeta-Analysis
In one paragraph

Synthesis in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Teresa SchätzlInstitute of Precision Medicine, Furtwangen University, Furtwangen, Germany.
Vanessa TodorowFriedrich-Baur-Institute at the Department of Neurology, LMU University Hospital, Ludwig Maximilian University, Munich, Germany.
Lars KaiserInstitute of Precision Medicine, Furtwangen University, Furtwangen, Germany.
Helga WeinschrottInstitute of Precision Medicine, Furtwangen University, Furtwangen, Germany.
Benedikt SchoserFriedrich-Baur-Institute at the Department of Neurology, LMU University Hospital, Ludwig Maximilian University, Munich, Germany.
Hans-Peter DeignerInstitute of Precision Medicine, Furtwangen University, Furtwangen, Germany.
Peter MeinkeFriedrich-Baur-Institute at the Department of Neurology, LMU University Hospital, Ludwig Maximilian University, Munich, Germany.
Matthias KohlInstitute of Precision Medicine, Furtwangen University, Furtwangen, Germany. matthias.kohl@stamats.de.ORCID 0000-0001-9514-8910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common autosomal dominant muscle disorders, yet no cure or amelioration exists. The clinical presentation is diverse, making it difficult to identify the actual driving pathomechanism among many downstream events. To unravel this complexity, we performed a meta-analysis of 13 original omics datasets (in total 171 FSHD and 129 control samples). Our approach confirmed previous findings about the disease pathology and specified them further. We confirmed increased expression of former proposed DUX4 biomarkers, and furthermore impairment of the respiratory chain. Notably, the meta-analysis provides insights about so far not reported pathways, including misregulation of neuromuscular junction protein encoding genes, downregulation of the spliceosome, and extensive alterations of nuclear envelope protein expression. Finally, we developed a publicly available shiny app to provide a platform for researchers who want to search our analysis for genes of interest in the future.

Indexed as

Muscular Dystrophy, FacioscapulohumeralNeuromuscular JunctionNuclear EnvelopeSpliceosomesGene Expression RegulationHomeodomain ProteinsHumansDUX4L1 protein, humanHomeodomain Proteins

Identifiers

PMID38796645
PMCPMC11127974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.